147 related articles for article (PubMed ID: 8897518)
21. Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma.
Straume O; Sviland L; Akslen LA
Clin Cancer Res; 2000 May; 6(5):1845-53. PubMed ID: 10815907
[TBL] [Abstract][Full Text] [Related]
22. Expression of p53 protein has no independent prognostic value in breast cancer.
Pietiläinen T; Lipponen P; Aaltomaa S; Eskelinen M; Kosma VM; Syrjänen K
J Pathol; 1995 Nov; 177(3):225-32. PubMed ID: 8551383
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.
Clemente CG; Mihm MC; Bufalino R; Zurrida S; Collini P; Cascinelli N
Cancer; 1996 Apr; 77(7):1303-10. PubMed ID: 8608507
[TBL] [Abstract][Full Text] [Related]
24. Flow cytometric analysis of p53 oncoprotein expression in cutaneous melanoma.
Ross DA; Wilson GD
Br J Surg; 1997 Jun; 84(6):803-7. PubMed ID: 9189093
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of p53 accumulation in epithelial ovarian carcinomas.
Berker B; Dunder I; Ensari A; Cengiz SD
Arch Gynecol Obstet; 2002 Aug; 266(4):205-9. PubMed ID: 12192480
[TBL] [Abstract][Full Text] [Related]
26. p53 expression in cutaneous malignant melanoma: an immunohistochemical study of 87 cases of primary, recurrent, and metastatic melanoma.
Barnhill RL; Castresana JS; Rubio MP; Martin MT; Idoate M; Vazquez JJ; Thor AD
Mod Pathol; 1994 Jun; 7(5):533-5. PubMed ID: 7937717
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of growth arrest, DNA damage genes and tumour suppressor gene p53 in naevi and malignant melanomas.
Korabiowska M; Betke H; Kellner S; Stachura J; Schauer A
Anticancer Res; 1997; 17(5A):3697-700. PubMed ID: 9413226
[TBL] [Abstract][Full Text] [Related]
28. Expression of apoptotic and proliferation markers in meningiomas.
Konstantinidou AE; Pavlopoulos PM; Patsouris E; Kaklamanis L; Davaris P
J Pathol; 1998 Nov; 186(3):325-30. PubMed ID: 10211124
[TBL] [Abstract][Full Text] [Related]
29. Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma.
Gimotty PA; Van Belle P; Elder DE; Murry T; Montone KT; Xu X; Hotz S; Raines S; Ming ME; Wahl P; Guerry D
J Clin Oncol; 2005 Nov; 23(31):8048-56. PubMed ID: 16258103
[TBL] [Abstract][Full Text] [Related]
30. Ki67 immunohistochemistry: a valuable marker in prognostication but with a risk of misclassification: proliferation subgroups formed based on Ki67 immunoreactivity and standardized mitotic index.
Jalava P; Kuopio T; Juntti-Patinen L; Kotkansalo T; Kronqvist P; Collan Y
Histopathology; 2006 May; 48(6):674-82. PubMed ID: 16681683
[TBL] [Abstract][Full Text] [Related]
31. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
[TBL] [Abstract][Full Text] [Related]
32. Expression of mutant p53 in melanoma.
Stretch JR; Gatter KC; Ralfkiaer E; Lane DP; Harris AL
Cancer Res; 1991 Nov; 51(21):5976-9. PubMed ID: 1933861
[TBL] [Abstract][Full Text] [Related]
33. Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate.
Svobodová S; Browning J; MacGregor D; Pollara G; Scolyer RA; Murali R; Thompson JF; Deb S; Azad A; Davis ID; Cebon JS
Eur J Cancer; 2011 Feb; 47(3):460-9. PubMed ID: 21115342
[TBL] [Abstract][Full Text] [Related]
34. High nuclear grade, frequent mitotic activity, cyclin D1 and p53 overexpression are associated with stromal invasion in mammary intracystic papillary carcinoma.
Zhang C; Zhang P; Hao J; Quddus MR; Steinhoff MM; Sung CJ
Breast J; 2005; 11(1):2-8. PubMed ID: 15647071
[TBL] [Abstract][Full Text] [Related]
35. Primary malignant melanoma of the skin. Relationships of nuclear DNA content, nuclear morphometric variables, Clark level and tumor thickness.
Talve LA; Collan YU; Ekfors TO
Anal Quant Cytol Histol; 1997 Feb; 19(1):62-74. PubMed ID: 9051188
[TBL] [Abstract][Full Text] [Related]
36. The nuclei in cutaneous malignant melanoma, stage I, are smaller in survivors than in non-survivors.
Tosi P; Luzi P; Sforza V; Santopietro R; Vindigni C; Miracco C; Baak JP; Smolle J; Barbini P
Pathol Res Pract; 1989 Nov; 185(5):625-30. PubMed ID: 2626373
[TBL] [Abstract][Full Text] [Related]
37. Etiologic factors associated with p53 immunostaining in cutaneousmalignant melanoma.
Purdue MP; From L; Kahn HJ; Armstrong BK; Kricker A; Gallagher RP; McLaughlin JR; Klar NS; Marrett LD
Int J Cancer; 2005 Nov; 117(3):486-93. PubMed ID: 15900597
[TBL] [Abstract][Full Text] [Related]
38. The adjuvant prognostic value of nuclear morphometry in stage I malignant melanoma of the skin. A multivariate analysis.
Baak JP; Tan GJ
Anal Quant Cytol Histol; 1986 Sep; 8(3):241-4. PubMed ID: 3778616
[TBL] [Abstract][Full Text] [Related]
39. Morphometric analysis in prognostic evaluation of stage I thick cutaneous melanomas.
Mauri MF; Boi S; Micciolo R; Cristofolini M; Dalla Palma P
Anal Quant Cytol Histol; 1997 Aug; 19(4):311-5. PubMed ID: 9267564
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical analysis of the N-ras p21 and the p53 proteins in naevi, primary tumours and metastases of human cutaneous malignant melanoma: increased immunopositivity in hereditary melanoma.
Platz A; Ringborg U; Grafström E; Höög A; Lagerlöf B
Melanoma Res; 1995 Apr; 5(2):101-6. PubMed ID: 7620336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
